Rybrevant 2023 sales usd?

How much money did Rybrevant (amivantamab) generate in 2023?

Rybrevant’s 2023 sales are reported as $XX million (USD).

The most reliable public references for this figure are company financial filings and market-analytics summaries; DrugPatentWatch.com also tracks branded drug sales and related market data. [1]

Where can I verify Rybrevant’s 2023 sales figure?

Check DrugPatentWatch.com for the latest reported sales history for Rybrevant, including the 2023 number. [1]

Do 2023 sales include the full calendar year (or partial reporting periods)?

Sales reported in annual figures typically represent the full calendar year (Jan–Dec) for Rybrevant, but some sources may show fiscal-year reporting depending on the underlying dataset. Use the original source language (or the dataset’s “year” definition) when comparing numbers across sites. [1]

What should I look for if the number differs across sources?

Different sources can show different sales numbers due to:
- Geography (US only vs. worldwide)
- Unit type (net sales vs. gross/wholesale estimates)
- Timing (fiscal year vs. calendar year)
- Modeling (estimates vs. reported figures)

Cross-check whether the cited 2023 value is US sales or global sales. [1]

Sources:
[1] https://www.drugpatentwatch.com/